• Organized by the Department of Pharmaceuticals (DoP), Ministry of Chemicals & Fertilizers, in association with Federation of Indian Chambers of Commerce and Industry (FICCI) and Indian Pharmaceutical Alliance (IPA), India Pharma 2026 is a flagship initiative aimed at promoting India’s pharmaceutical sector
• Initiative to showcase India’s pharmaceutical prowess, promote innovation, and strengthen the global supply chain

New Delhi, 30 March 2026: The Department of Pharmaceuticals (DoP), Ministry of Chemicals & Fertilizers, Government of India, in association with the Federation of Indian Chambers of Commerce and Industry (FICCI) and the Indian Pharmaceutical Alliance (IPA), is proud to announce the 9th Edition of India Pharma 2026. This flagship event is scheduled to take place on April 13th and 14th, 2026, at Federation House, New Delhi.

Theme: Discover in India: Leapfrogging life-sciences innovation

 Aligned with India’s vision of becoming a global innovation hub, the theme emphasizes transformative advancements in life sciences that can enhance healthcare access, drive economic growth, and strengthen global health security.

As the “Pharmacy of the World,” India has consistently proven its mettle in providing affordable, high-quality medicines to the world. The 2026 edition of India Pharma serves as a strategic catalyst to transition the Indian pharmaceutical sector from a “volume-driven” model to a “value-and-innovation-driven” global powerhouse.

The initiative is designed to highlight India’s manufacturing excellence and its burgeoning R&D ecosystem. By bringing together global leaders, policymakers, and researchers, the event aims to foster an environment conducive to drug discovery, complex generics, and biosimilars.

 For more information about the 9th Edition of India Pharma 2026, visit: https://indiapharma.ficci.in/